Global EditionASIA 中文双语Français
Home / World / Asia-Pacific

Indian company gets manufacturing license for Russia's COVID-19 vaccine Sputnik V

Xinhua | Updated: 2021-07-05 09:11
Share - WeChat

MUMBAI -- India's Panacea Biotec has received manufacturing license to produce Russia's COVID-19 vaccine, Sputnik V, the company said Sunday.

The license was granted by India's drug regulator pursuant to Panacea Biotec's collaboration with Russian Direct Investment Fund, the sovereign wealth fund.

Earlier in May, the batches of vaccine were produced at Panacea Biotec's facilities in India and were shipped to the Gamaleya Center in Russia for quality control and they have successfully cleared all quality parameters both in Russia as well as in India, the company said.

In April, Sputnik V was registered in India under the emergency use authorization procedure and the inoculation in India with the imported vaccines from Russia started in May by another Indian company, Dr Reddy's Laboratories, who too has approval from the Russia's sovereign wealth fund.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349